Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Apollomics Inc. Class A Ordinary Shares
APLM | US
0.14
USD0.01
6.79%
APLM | US
About Apollomics Inc. Class A Ordinary Shares
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
0.14
Open
0.13
High
0.14
Low
0.13
Apollomics Inc. a biotechnology company engages in the discovery and development of oncology therapies to address unmet medical needs in California Hangzhou Shanghai China and Australia. It develops APL-101 (Vebreltinib) a potent selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active small molecule multiple tyrosine kinase inhibitor for liver cancer breast cancer and esophageal cancer; and APL-122 a tumor inhibitor candidate to treat cancers within the brain. The company was formerly known as CBT Pharmaceuticals Inc. and changed its name to Apollomics Inc. in January 2019. Apollomics Inc. was incorporated in 2015 and is based in Foster City California.
View LessAPLM | US
Risk
84.4
Sharpe
-0.84
Luna's Score
55/100
Recommendation
Hold
Luna says (APLM | US)
What's Working
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
76.7%1 month
84.4%3 months
85.1%6 months
82.4%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.68
Debt to equity
0.21
Debt to assets
0.13
Ent. to EBITDA
-0.10
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-53.10M
MarketCap
15.04M
MarketCap(USD)
15.04M
Div. yield
-
Op. margin
-1.43K
Erngs. growth
-
Rev. growth
262.30
Ret. on equity
-149.31
Short ratio
0.27
Short perc.
0.26
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.04
Range1M
0.06
Range3M
0.18
Volumes: Market Activity
Rel. volume
1.09
Price X volume
127.10K
